{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:45:38Z","timestamp":1789062338354,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/ncc.0b013e318211fa92","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T05:20:14Z","timestamp":1305004814000},"page":"63-69","source":"Crossref","is-referenced-by-count":41,"title":["Andropause Syndrome in Men Treated for Metastatic Prostate Cancer"],"prefix":"10.1097","volume":"35","author":[{"given":"Elizabeth A.","family":"Grunfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Drudge-Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1470-2045(09)70028-2","article-title":". Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.","volume":"10","author":"Rachet","year":"2009","journal-title":"Lancet Oncol"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":". Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1464-410X.2009.08695.x","article-title":"Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.","volume":"104","author":"Vis","year":"2009","journal-title":"BJU Int"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-4295(91)80077-K","article-title":". Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. The Zoladex Prostate Study Group.","volume":"37","author":"Soloway","year":"1991","journal-title":"Urology"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":". Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.urology.2009.03.003","article-title":"Current prostate cancer treatments: effect on quality of life.","volume":"73","author":"Gomella","year":"2009","journal-title":"Urology"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1634\/theoncologist.8-5-474","article-title":"Andropause: symptom management for prostate cancer patients treated with hormonal ablation.","volume":"8","author":"Thompson","year":"2003","journal-title":"Oncologist"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-771X.2007.00005.x","article-title":"Bone health: the effect of androgen deprivation therapy in prostate cancer patients.","volume":"1","author":"Drudge-Coates","year":"2007","journal-title":"Int J Urol Nurs"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-771X.2008.00065.x","article-title":"Gynaecomastia: a case study review of the effect of hormone therapy in the management of prostate cancer.","volume":"2","author":"Drudge-Coates","year":"2008","journal-title":"Int J Urol Nurs"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2001.19.1.72","article-title":"Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer.","volume":"19","author":"Clark","year":"2001","journal-title":"J Clin Oncol"},{"key":"R13-8-20210203","first-page":"263","article-title":"Incidence and management of hot flashes in prostate cancer.","volume":"1","author":"Spetz","year":"2003","journal-title":"J Support Oncol"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-5347(17)37432-3","article-title":"The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer.","volume":"147","author":"Miller","year":"1992","journal-title":"Urol"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)65973-3","article-title":"Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.","volume":"166","author":"Spetz","year":"2001","journal-title":"J Urol"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1442-2042.2004.00896.x","article-title":"Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.","volume":"11","author":"Nishiyama","year":"2004","journal-title":"Int J Urol"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0885-3924(98)00090-6","article-title":"Definitions of hot flashes in breast cancer survivors.","volume":"16","author":"Finck","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.maturitas.2009.06.003","article-title":"Menopausal symptoms following breast cancer treatment: a qualitative investigation of cognitive and behavioural responses.","volume":"63","author":"Hunter","year":"2009","journal-title":"Maturitas"},{"key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0022-5347(17)32530-2","article-title":"Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma.","volume":"52","author":"Karling","year":"1994","journal-title":"J Urol"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1517\/14656566.6.7.1095","article-title":"Treatment of hot flushes in breast and prostate cancer.","volume":"6","author":"Adelson","year":"2005","journal-title":"Exp Opin Pharmacother"},{"key":"R21-8-20210203","first-page":"1","article-title":"Measuring hot flashes in men treated with hormone ablation therapy; an unmet need.","volume":"26","author":"Kattan","year":"2006","journal-title":"Urol Nurs"},{"key":"R22-8-20210203","first-page":"226","article-title":"Carrying out qualitative analysis. In: Ritchie J, Lewis J, eds. Qualitative Research Practice; A Guide for Social Science Students and Researchers.","volume":"219-","author":"Ritchie","year":"2003","journal-title":"London: Sage Publications"},{"key":"R23-8-20210203","first-page":"597","article-title":"Understanding reliability and validity in qualitative research.","volume":"8","author":"Golafshani","year":"2003","journal-title":"Qual Rep"},{"key":"R24-8-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.17763\/haer.62.3.8323320856251826","article-title":"Understanding and validity in qualitative research.","volume":"62","author":"Maxwell","year":"1992","journal-title":"Harv Educ Rev"},{"key":"R25-8-20210203","first-page":"S35","article-title":"Hormonal therapy for prostate cancer.","volume":"8","author":"Brawer","year":"2006","journal-title":"Rev Urol"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13697130500515776","article-title":"Mid-Age Health in Women from the Indian Subcontinent (MAHWIS): general health and the experience of menopause in women.","volume":"9","author":"Gupta","year":"2006","journal-title":"Climacteric"},{"key":"R27-8-20210203","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","article-title":". Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes.","volume":"82","author":"Quella","year":"1998","journal-title":"Cancer"},{"key":"R28-8-20210203","first-page":"1087","article-title":"Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate.","volume":"17","author":"Burch","year":"1991","journal-title":"J Clin Oncol"},{"key":"R29-8-20210203","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":". Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"R30-8-20210203","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":". Phase III evaluation of fluoxetine for treatment of hot flashes.","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"R31-8-20210203","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pon.1414","article-title":"Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment.","volume":"18","author":"Hunter","year":"2009","journal-title":"Psychooncology"},{"key":"R33-8-20210203","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.socscimed.2006.01.027","article-title":"Patients perceptions of the side-effects of prostate cancer treatmenta qualitative interview study.","volume":"63","author":"Korfage","year":"2006","journal-title":"Soc Sci Med"},{"key":"R34-8-20210203","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.socscimed.2004.10.016","article-title":"Constructions of masculinity following prostatectomy-induced impotence.","volume":"60","author":"Oliffe","year":"2005","journal-title":"Soc Sci Med"},{"key":"R35-8-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ijir.2008.66","article-title":". The psychosocial aspects of sexual recovery after prostate cancer treatment.","volume":"21","author":"Wittmann","year":"2009","journal-title":"Int J Impot Res"},{"key":"R36-8-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2407-8-226","article-title":". ProsCan for Couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy.","volume":"8","author":"Chambers","year":"2008","journal-title":"BMC Cancer"},{"key":"R37-8-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.pcan.4500859","article-title":". Gynecomastia in patients with prostate cancer: update on treatment options.","volume":"9","author":"Autorino","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R38-8-20210203","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1467-9566.2006.00499.x","article-title":"Embodied masculinity and androgen deprivation therapy.","volume":"28","author":"Oliffe","year":"2006","journal-title":"Sociol Health Illn"},{"key":"R39-8-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.ijir.3901220","article-title":"Beliefs about illness and quality of life among men with erectile dysfunction.","volume":"17","author":"Stamogiannou","year":"2005","journal-title":"Int J Impot Res"},{"key":"R40-8-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-1800.2005.00258.x","article-title":"Men, culture and hegemonic masculinity: understanding the experience of prostate cancer.","volume":"12","author":"Wall","year":"2005","journal-title":"Nurs Inq"},{"key":"R41-8-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/1099-1611(200007\/08)9:4<273::AID-PON463>3.0.CO;2-F","article-title":"To tell or not to tell: patterns of disclosure among men with prostate cancer.","volume":"9","author":"Gray","year":"2000","journal-title":"Psychooncology"}],"container-title":["Cancer Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002820-201201000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:29:53Z","timestamp":1786044593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002820-201201000-00008"}},"subtitle":["A Qualitative Study of the Impact of Symptoms"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ncc.0b013e318211fa92","relation":{},"ISSN":["0162-220X"],"issn-type":[{"value":"0162-220X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}